These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6460991)

  • 1. Alpha blockade in pulmonary hypertension.
    Cottrell AJ; Pearson DT; Hunter S
    Pediatr Cardiol; 1982; 2(1):89-90. PubMed ID: 6460991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Basic principles of the current treatment of primary pulmonary hypertension].
    Konopleva LF; Revutskiĭ EL; Previr VN
    Kardiologiia; 1984 Oct; 24(10):121-5. PubMed ID: 6394865
    [No Abstract]   [Full Text] [Related]  

  • 3. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery.
    Hirono K; Yoshimura N; Taguchi M; Watanabe K; Nakamura T; Ichida F; Miyawaki T
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):346-51. PubMed ID: 20434177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan and pulmonary hypertension.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic alterations in pulmonary artery pressure in the adult respiratory distress syndrome.
    Weigelt JA; Gewertz BL; Aurbakken CM; Snyder WH
    J Surg Res; 1982 Mar; 32(3):243-8. PubMed ID: 7070077
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P; Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obstructive pulmonary hypertension: effect of aminophylline, hyperventilation and O 2 respiration].
    Renggli I; Daum S
    Schweiz Med Wochenschr; 1971 Mar; 101(10):352-7. PubMed ID: 5558550
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
    J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
    Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pulmonary hypertension; favorable effect of isoproterenol.
    Shettigar UR; Hultgren HN; Specter M; Martin R; Davies DH
    N Engl J Med; 1976 Dec; 295(25):1414-5. PubMed ID: 980096
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
    LeVarge BL; Channick RN
    Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucagon on pulmonary vascular resistance.
    Kirsh MM; Kahn DR; Lucchesi B; Gago O; Dufek JH; Lee RW; Stutz D; Sloan H
    Surgery; 1971 Sep; 70(3):439-42. PubMed ID: 5568529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nifedipine in the treatment of pulmonary hypertension. II--Hypoxic pulmonary hypertension].
    Barreto BM; de Freitas FM
    Arq Bras Cardiol; 1986 Jun; 46(6):425-9. PubMed ID: 3579636
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of euphylline on the hemodynamics of patients with congenital heart defects with and without pulmonary hypertension].
    Chepkii LP; Shubin MK; Panichkin IuV; Nikishin NF; Brusan LA
    Kardiologiia; 1969 Jun; 9(6):60-4. PubMed ID: 5806638
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cromakalim inhibits endothelin-1 induced pulmonary hypertension in rats].
    Cheng D; Chen W; Xiao X
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Mar; 29(1):79-81, 94. PubMed ID: 10683987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in 2012: contemporary issues in diagnosis and management.
    Lau EM; Corte TJ
    Panminerva Med; 2012 Mar; 54(1):11-28. PubMed ID: 22278113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.